The global neuroscience market reached a valuation of USD 35.9 billion in 2024 and is projected to grow to USD 48.0 billion by 2033, reflecting a steady CAGR of 3.1% during 2025–2033. This growth is fueled by increasing neurological disorder prevalence, technological advancements in neuroimaging, and rising investments in research and development. Additionally, growing awareness of mental health issues, expanding applications in neuroinformatics and neuroprosthetics, and supportive government policies are contributing to market expansion.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019–2024
- Forecast Years: 2025–2033
Neuroscience Market Key Takeaways
- Market Size & Growth: Valued at USD 35.9 billion in 2024, the market is expected to reach USD 48.0 billion by 2033, growing at a CAGR of 3.1% during the forecast period.
- Technological Advancements: Innovations in neuroimaging tools and the integration of AI and machine learning are enhancing diagnostics and personalized treatments.
- Rising Neurological Disorders: An increasing prevalence of conditions like epilepsy and Alzheimer's disease is driving demand for neuroscience research and therapies.
- Government Support: Supportive policies and funding initiatives are bolstering research and development activities in neuroscience.
- Aging Population: The growing elderly demographic is contributing to higher incidences of neurological ailments, necessitating advanced treatment options.
Market Growth Factors
- Rising prevalence of neurological and mental health disorders.
The increasing number of neurological and mental health disorders is driving a significant surge in the neuroscience market, creating a pressing need for better diagnostic and treatment options. As the global population ages, we see a rise in conditions such as Alzheimer's, Parkinson's, and dementia, which calls for more research and technology to tackle age-related neurodegeneration. Moreover, as public awareness grows and the stigma surrounding mental health diminishes, more individuals are reaching out for help, which in turn boosts the demand for psychiatric services, neuro-diagnostics, and digital health tools. This urgent need to understand, diagnose, and treat the escalating challenges posed by brain-related disorders is fueling investment in neuroscience research, sparking technological advancements, and broadening the market for both established and innovative interventions.
- Rapid technological advancements in neuroimaging and diagnostics.
Rapid advancements in neuroimaging and diagnostics are really shaking things up in the neuroscience market. They’re making it possible to detect and monitor neurological conditions earlier, more accurately, and in a way that’s more accessible to everyone. With innovations like AI-integrated fMRI and PET scans, we’re getting clearer images and automated analyses that boost diagnostic accuracy for diseases such as Alzheimer’s and epilepsy. Plus, the rise of portable and wearable neuro-technologies, like EEG headbands and mobile tracking apps, is steering the market toward a more proactive approach to brain health management, especially in areas that need it most. These cutting-edge diagnostic tools are not just supporting personalized treatment plans; they’re also enhancing clinical decision-making and driving growth to meet the rising demand for effective neurological care.
- Technological innovations like brain-computer interfaces (BCIs)
Technological advancements in Brain-Computer Interfaces (BCIs) are sparking remarkable growth in the neuroscience market by creating exciting opportunities for both medical and non-medical uses. These BCI systems, which convert brain signals into commands for various devices, are making rapid strides thanks to better signal processing and AI-driven decoding. In the healthcare sector, BCIs are transforming neurorehabilitation and assistive technologies, allowing people with severe motor disabilities to control prosthetic limbs or communicate just by thinking. At the same time, the rise of non-invasive, wearable BCI devices is broadening the market into areas like consumer electronics, gaming, and mental wellness, making this technology more accessible to everyone. This expansion in both clinical and consumer markets is a major driver of growth.
Request for a sample copy of this report:
https://www.imarcgroup.com/neuroscience-market/requestsample
Market Segmentation
By Component
- Instruments and Consumables: Includes devices and materials used in neuroscience research and diagnostics.
- Software and Services: Comprises analytical tools and support services facilitating neuroscience studies.
By Technology
- Brain Imaging: Techniques like MRI and PET scans used for visualizing brain structures and functions.
- Neuro-Microscopy: Microscopic methods for examining neural tissues at cellular levels.
- Electrophysiology: Studies electrical properties of biological cells and tissues in the nervous system.
- Neuroproteomic Analysis: Analyzes protein expressions and functions in neural contexts.
- Animal Behaviour Analysis: Observes and interprets behavioral patterns in animal models for neurological studies.
- Others: Encompasses additional emerging technologies in neuroscience research.
By End User
- Hospitals: Healthcare institutions providing diagnostic and therapeutic services for neurological conditions.
- Diagnostic Laboratories: Facilities specializing in testing and analysis of neurological samples.
- Research and Academic Institutes: Organizations conducting neuroscience research and education.
- Others: Includes other entities involved in neuroscience applications.
By Region
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Regional Insights
North America leads the neuroscience market, driven by advanced healthcare infrastructure, significant investments in research and development, and the presence of key industry players. The region's focus on technological innovation and early adoption of advanced diagnostic tools contributes to its dominant position in the global market.
Recent Developments & News
In January 2025, the President of India inaugurated advanced facilities at the National Institute of Mental Health and Neurosciences (NIMHANS) in Bengaluru, including an AI-enabled 3T MRI scanner, enhancing diagnostic capabilities in mental health. Additionally, in December 2024, Medtronic launched the FDA-approved Percept RC neurostimulator in India, designed for deep brain stimulation in patients with movement disorders like Parkinson’s and epilepsy. This innovative device features integrated sensing and a long-lasting rechargeable battery, aiming to provide personalized treatments and improve patient outcomes in neurological care.
Key Players
Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., Siemens AG, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5133&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
